Suppr超能文献

坦索罗辛与坦索罗辛联合他达拉非作为输尿管下段结石药物排石治疗的随机对照试验

Tamsulosin versus tamsulosin plus tadalafil as medical expulsive therapy for lower ureteric stones: a randomized controlled trial.

作者信息

Jayant Kumar, Agrawal Rajendra, Agrawal Swati

机构信息

Department of Urology, Sudha Hospital and Medical Research Centre, Kota, Rajasthan, India.

出版信息

Int J Urol. 2014 Oct;21(10):1012-5. doi: 10.1111/iju.12496. Epub 2014 Jun 3.

Abstract

OBJECTIVES

To compare the efficacy of tamsulosin versus tamsulosin plus tadalafil as medical expulsive therapy for lower ureteric stones.

METHODS

Between January 2013 and December 2013, 244 patients presenting with distal ureteric stones (size 5-10 mm) were randomized equally to tamsulosin (group A) or tamsulosin plus tadalafil (group B). Therapy was given for a maximum of 4 weeks. Stone expulsion rate, time to stone expulsion, analgesic use, number of hospital visits for pain, follow up, endoscopic treatment and adverse effects of drugs were recorded. Statistical analyses were carried out using Student's t-test and the χ(2) -test.

RESULTS

There was a statistically significant higher expulsion rate in group B compared with group A (83.6% vs 65.5%; P-value = 0.031) and a shorter time to expulsion (14.9 ± 4.4 days vs 16.7 ± 4.8 days; P-value = 0.003). Statistically significant differences were noted in terms of the number of hospital visits and analgesic requirement in favor of group B. There was no serious adverse event. An improvement in erectile function was noted in patients of group B compared with those of group A.

CONCLUSIONS

Medical expulsive therapy for distal ureteric stones using tamsulosin plus tadalafil is safe, effective and well tolerated. Furthermore, tadalafil provides the additional advantage of improving erectile dysfunction when this condition coexists with a lower ureteric stone.

摘要

目的

比较坦索罗辛与坦索罗辛联合他达拉非作为输尿管下段结石药物排石疗法的疗效。

方法

在2013年1月至2013年12月期间,将244例输尿管下段结石(大小为5 - 10毫米)患者随机均分为坦索罗辛组(A组)和坦索罗辛联合他达拉非组(B组)。治疗最长持续4周。记录结石排出率、结石排出时间、镇痛药物使用情况、因疼痛就诊次数、随访情况、内镜治疗及药物不良反应。采用学生t检验和χ²检验进行统计学分析。

结果

B组的结石排出率显著高于A组(83.6%对65.5%;P值 = 0.031),且排出时间更短(14.9 ± 4.4天对16.7 ± 4.8天;P值 = 0.003)。在就诊次数和镇痛需求方面,B组有统计学显著差异。未发生严重不良事件。与A组患者相比,B组患者的勃起功能有改善。

结论

坦索罗辛联合他达拉非用于输尿管下段结石的药物排石疗法安全、有效且耐受性良好。此外,当输尿管下段结石合并勃起功能障碍时,他达拉非还具有改善勃起功能障碍的额外优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验